(Q40287396)
Statements
Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapy (English)
Bjørge L
Stoiber H
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference